Canaccord Genuity Reiterates Buy Rating on AxoGen, Inc. (AXGN)
Tweet Send to a Friend
Canaccord Genuity analyst Caitlin Cronin reiterated a Buy rating and $37.00 price target on AxoGen, Inc. (NASDAQ: AXGN).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
